Download these slides from a live symposium at ONS 2022 featuring best testing practices for advanced NSCLC and the latest evidence on novel therapies available for the treatment of EGFR ex20ins–positive disease.
Download these slides from a live symposium at ONS 2022 featuring review of the toxicity profiles of novel therapies available for the treatment of EGFR ex20ins–positive disease, along with guidance for nurses on best practices for monitoring and management of adverse events and patient education.
Gain clinical insights fast, with this short summary slideset of key takeaways from a live symposium at ONS 2022 on how experts approach management of patients with EGFR ex20ins+ advanced NSCLC.
Download this reference guide for key points on patient counseling, monitoring, and managing toxicities associated with approved therapies targeting EGFR exon 20 insertions in patients with NSCLC.
Watch this on-demand webcast of a live CCO webinar where an oncology nurse practitioner and a medical oncologist discuss management of EGFR exon 20 insertion–positive advanced non‑small-cell lung cancer, from biomarker testing to monitoring and management strategies for adverse events with new therapies targeting this alteration.